Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR20004 gastric emptying study in healthy subjects
NCT06137469Phase 1Completed
- Sponsor
- Hengrui
- Start
- Dec 2023
- Primary completion
- Mar 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Acetaminophen+SHR20004 with Acetaminophen+Placebo (2 arms). Primary endpoint: Pharmacokinetics parameters of acetaminophen (AUC0-300min) at Day 31. Started Dec 2023; status: completed.
02
Drugs
noiiglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06137469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06137469.